logo
welcome
markets.businessinsider.com

markets.businessinsider.com

Moderna and other vaccine maker shares jump after first US bird flu death

markets.businessinsider.com
Summary
Nutrition label

85% Informative

Moderna , Novavax , and CureVac saw double-digit gains, while Pfizer and GSK also rose.

Moderna won a $176 million award from the US government in July to develop the shot.

The CDC reported the first death from bird flu in the US on Monday .